Ledger.Open graph →

SEC Form D · filed January 14, 2021

Novosteo Inc

Offering

$6.5M

Sold

$4.3M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

WEST LAFAYETTE, IN

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Alex S. Andrianopoulos · West Lafayette, INDirector Philip S. Low, Ph.D · West Lafayette, INExec · Director Pascal S. Krotee · West Lafayette, INDirector Dan S. Hasler · West Lafayette, INDirector Copernico Capital Partners (Bermuda) Ltd · Hamilton, BermudaExec · Director Ocean Arete Limited · Central, Hong KongDirector William J. Boyle, Ph.D · West Lafayette, INExec · Director Stewart A. Low, Ph.D · West Lafayette, INExec Toshiyuki Okayasu · Tokyo, M0Exec · Director Ricky Sim · Tokyo, M0Director William J. Boyle, Ph.D · West Lafayette, INExec · Director Stewart A. Low, Ph.D · West Lafayette, INExec Pascal S. Krotee · West Lafayette, INDirector Dan S. Hasler · West Lafayette, INDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗